Effie Albanis, M.D., Senior Vice President, Early Clinical and Translational Research

Effie Albanis, M.D., serves as Senior Vice President, Early Clinical and Translational Research at Neurogene. Dr. Albanis brings to the team more than a decade of pharmaceutical and biotechnology industry experience. She joined Neurogene in 2018, and works with the preclinical, regulatory, and clinical teams to ensure robust translational science is applied to discovery-stage products to support advancement into the clinic. Prior to her work at Neurogene, she served in roles of increasing responsibility focused on liver disease in clinical development, medical affairs, and strategy at Novartis, Pharmasset, and Intercept Pharmaceuticals. Dr. Albanis received her M.D. from the Mount Sinai School of Medicine, and completed her internal medicine, gastroenterology, and hepatology training at the Mount Sinai Medical Center. During her tenure, she worked as a physician-scientist focused on grant-supported translational research in hepatic fibrosis while also managing advanced, decompensated hepatology patients in her practice. She remains on faculty at the Mount Sinai School of Medicine.